Welcome to our dedicated page for First Phosphate news (Ticker: FPHOY), a resource for investors and traders seeking the latest updates and insights on First Phosphate stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect First Phosphate's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of First Phosphate's position in the market.
First Phosphate (OTCQX:FPHOY) launched a sponsored Level 1 American Depositary Receipt (ADR) program trading on OTCQX under symbol FPHOY effective February 12, 2026, at a ratio of 10 common shares per ADR. The Bank of New York Mellon is depositary bank.
The company received an initial offtake payment of USD $523,017.59, recorded option exercises by a director-controlled entity, and authorized RSU grants totalling 1,975,000 to board, management and staff; 781,395 RSUs were issued to ExpoWorld to cashlessly settle terminated options.